Obesity, diabetes, cardiovascular and hormone-related diseases are closely related and growing in number of affected individuals worldwide. This is reflected in the 13 million Danish kroner research grant allocation from the Danish Diabetes and Endocrine Academy (DDEA) to 13 Danish and international early-career researchers and three visiting professors.
The grant is, among other things, going to help early-career researchers better understand the mechanisms behind appetite-regulating hormones; the prevention of type 2 diabetes in young couples with a history of gestational diabetes; how to reduce cardiovascular complications to diabetes through dietary supplements and artificial intelligence; and which effect it has to use frozen/thawed eggs versus fresh eggs in fertility treatment for the child’s further development.
– The funded projects will establish strong collaborations across leading universities, research academies, hospitals and life science industry. They cover a wide field from basic research that may lead to future medicinal products to biomarkers that can predict the healing of diabetic foot ulcers, and to clinical research that will benefit the end user relatively fast, says Chairman of the DDEA Board of Directors, Allan Flyvbjerg.
Allan Flyvbjerg points out that the grant competition has been extremely high.
– The international grant review committee has judged all funded projects to be of the highest international quality. The chosen early-career researchers will make a significant difference for people with obesity, diabetes, cardiovascular and/or hormone-related diseases, their relatives and society, says Allan Flyvbjerg.
For the first time, the DDEA collaborates with the Danish Cardiovascular Academy (DCA) about three cross-academy scholarships. Allan Flyvbjerg and Director of DCA, Christian Aalkjær, are happy that the academies have the possibility to support the next generation of early-career researchers and clinicians within diabetes, hormone-related and cardiovascular diseases.
In total, the Danish Diabetes and Endocrine Academy (DDEA) has allocated 13,040,000 DKK. Read more about the 16 grant recipients.
Three scholarships are allocated in cooperation with the Danish Cardiovascular Academy and two with support from Novo Nordisk and Zealand Pharma.
The next call for applications will open 20 June 2023 with application deadline 23 August 2023.
The DDEA is funded by the Novo Nordisk Foundation 2022 – 2027.
Chairman of Board of Directors, Allan Flyvbjerg
Tel.: 0045 5177 9548
E-mail: allan.flyvbjerg1@outlook.dk
Managing Director, Tore Christiansen
Tel.: 0045 2964 6764
E-mail: tore.christiansen@rsyd.dk
Visiting Professor David Beran has now finished his white book that compiles existing data on type 1 diabetes in Denmark. Together with the just published article ”Type 1 Diabetes and Health Information Systems: Lessons from Denmark” in the European Medical Journal, the hope is that the white book will be used a...
Center for Clinical Metabolic Research invites you to join their symposium on the novel LEAP2 peptide. LEAP2 has been identified as an antagonist of the hunger hormone ghrelin and is thus expected to play an important yet fairly undiscovered role in the regulation of appetite and metabolism. The symposium features p...
We are happy to welcome our Administrative Student Assistant, Svajūnė Gurklytė, to the DDEA Secretariat. In the role as Administrative Student Assistant, Svajūnė Gurklytė’s main task is to handle ad hoc administrative tasks related to the DDEA activities within education, networking, grants and communica...
From understanding carnivorous plants to developing antimicrobial strategies for pen injectors, Sofia Wareham Mathiassen’s research life is characterized by high levels of curiosity and inventiveness. And in many ways, she has only just begun. Sofia Wareham Mathiassen is a biomedical engineer from the Danish ...
Earlier this year saw the establishment of a new research centre focusing on making a difference for people with metabolic disease through RNA medicine. Professor of Medical Biology and member of the DDEA Committee for Education, Louise Torp Dalgaard, will be one of the driving forces behind the new centre. The Cent...
A study found a very high seroprevalence of SARS-CoV-2 antibodies in mother-children pairs in rural north-eastern Tanzania. Line Hjort shares her insights from the study, as well as from her time doing research in Tanzania while the country’s government was downplaying the COVID-19 pandemic. During the first year ...
A proof-of-concept study by DDA-funded Visiting Professor Sam El-Osta’s team demonstrates that ductal cells derived from the human pancreas can be influenced by pharmacological stimulation to regenerate beta-like cells that functionally release insulin. – While pharmaceutical options receive warranted attent...
The Danish Diabetes and Endocrine Academy’s Advisory Board is now complete with the announcement of five international members; Nicolas Dumoulin, Vet Met, PhD, Niki Karavitaki, MSc, PhD, Marta Korbonits, MD, PhD, Alan Moses, MD, and Mikael Ryden, MD, PhD. The aim of the Advisory Board ...
EAN: 5798 0022 30642
Reference: 1025 0006
CVR: 29 19 09 09
